Company news: Biogen-Idec, Bristol-Myers Squibb and Pfizer

February 29 2012

Biogen-Idec is submitting its multiple sclerosis drug BG-12 for formal FDA scrutiny.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.